These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 15867494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
    Alvarez-Martínez MJ, Miró JM, Valls ME, Mas J, de la Bellacasa JP, Sued O, Solé M, Rivas PV, de Lazzari E, Benito N, García F, Agustí C, Wilson PE, Gatell JM, Jiménez de Anta MT, Meshnick SR, Moreno A.
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
    [Abstract] [Full Text] [Related]

  • 3. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B.
    Lancet; 1999 Oct 16; 354(9187):1347-51. PubMed ID: 10533864
    [Abstract] [Full Text] [Related]

  • 4. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK, Mirdha BR, Luthra K, Guleria R, Mohan A, Singh UB, Samantaray JC, Dar L, Iyer VK, Chaudhry R.
    J Infect Dev Ctries; 2010 Nov 24; 4(11):761-6. PubMed ID: 21252456
    [Abstract] [Full Text] [Related]

  • 5. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality.
    Alvarez-Martínez MJ, Moreno A, Miró JM, Valls ME, Rivas PV, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, Santín M, Sirera G, Segura F, Vidal F, Rodríguez F, Riera M, Cordero ME, Arribas JR, Jiménez de Anta MT, Gatell JM, Wilson PE, Meshnick SR, Spanish PCP Working Group.
    Diagn Microbiol Infect Dis; 2008 Sep 24; 62(1):34-43. PubMed ID: 18554841
    [Abstract] [Full Text] [Related]

  • 6. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA, Chabé M, George C, Cárdenas A, Durán L, Guerrero J, Bustamante R, Matos O, Huang L, Miller RF, Vargas SL.
    Antimicrob Agents Chemother; 2017 Feb 24; 61(2):. PubMed ID: 27855071
    [Abstract] [Full Text] [Related]

  • 7. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda.
    Taylor SM, Meshnick SR, Worodria W, Andama A, Cattamanchi A, Davis JL, Yoo SD, Byanyima P, Kaswabuli S, Goodman CD, Huang L, International HIV-associated Opportunistic Pneumonias Study.
    PLoS One; 2012 Feb 24; 7(11):e49991. PubMed ID: 23166805
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of dihydropteroate synthase mutants in HIV-infected South African children with Pneumocystis jiroveci pneumonia.
    Zar HJ, Alvarez-Martinez MJ, Harrison A, Meshnick SR.
    Clin Infect Dis; 2004 Oct 01; 39(7):1047-51. PubMed ID: 15472859
    [Abstract] [Full Text] [Related]

  • 9. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.
    Singh Y, Mirdha BR, Guleria R, Kabra SK, Mohan A, Chaudhry R, Kumar L, Dwivedi SN, Agarwal SK.
    J Glob Antimicrob Resist; 2019 Jun 01; 17():236-239. PubMed ID: 30658203
    [Abstract] [Full Text] [Related]

  • 10. Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.
    Zhu M, Ye N, Xu J.
    PLoS One; 2020 Jun 01; 15(9):e0238184. PubMed ID: 32911508
    [Abstract] [Full Text] [Related]

  • 11. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
    Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, Carter JL, Le T, Hightower A, Rimland D.
    Lancet; 2001 Aug 18; 358(9281):545-9. PubMed ID: 11520525
    [Abstract] [Full Text] [Related]

  • 12. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.
    Rabodonirina M, Vaillant L, Taffé P, Nahimana A, Gillibert RP, Vanhems P, Hauser PM.
    Emerg Infect Dis; 2013 Jan 18; 19(1):21-8; quiz 186. PubMed ID: 23260763
    [Abstract] [Full Text] [Related]

  • 13. [Dihydropteroate Synthase (DHPS) Gene Mutations and Mitochondrial Large Subunit (mtLSU) rRNA Genotype Variations in Pneumocystis jirovecii Strains].
    Gülbudak H, Öztürk C, Kuyugöz S, Tezcan Ülger S.
    Mikrobiyol Bul; 2021 Jan 18; 55(1):41-52. PubMed ID: 33590980
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations.
    Matos O, Esteves F.
    Parasite; 2010 Sep 18; 17(3):219-32. PubMed ID: 21073145
    [Abstract] [Full Text] [Related]

  • 15. Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study.
    Tyagi AK, Mirdha BR, Luthra K, Guleria R, Mohan A, Singh UB, Samantaray JC, Dar L, Iyer VK, Sreenivas V.
    Med Mycol; 2011 Feb 18; 49(2):167-71. PubMed ID: 20718608
    [Abstract] [Full Text] [Related]

  • 16. Low prevalence of DHFR and DHPS mutations in Pneumocystis jirovecii strains obtained from a German cohort.
    Suárez I, Roderus L, van Gumpel E, Jung N, Lehmann C, Fätkenheuer G, Hartmann P, Plum G, Rybniker J.
    Infection; 2017 Jun 18; 45(3):341-347. PubMed ID: 28303545
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.
    Dini L, du Plessis M, Frean J, Fernandez V.
    J Clin Microbiol; 2010 Jun 18; 48(6):2016-21. PubMed ID: 20351205
    [Abstract] [Full Text] [Related]

  • 18. Study of DHPS and DHFR genes of Pneumocystis jirovecii in Thai HIV-infected patients.
    Siripattanapipong S, Leelayoova S, Mungthin M, Worapong J, Tan-Ariya P.
    Med Mycol; 2008 Jun 18; 46(4):389-92. PubMed ID: 18415849
    [Abstract] [Full Text] [Related]

  • 19. Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype.
    Valerio A, Tronconi E, Mazza F, Fantoni G, Atzori C, Tartarone F, Duca P, Cargnel A.
    J Acquir Immune Defic Syndr; 2007 Aug 15; 45(5):521-8. PubMed ID: 17558331
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients.
    Liao TY, Huang YT, Lee TF, Hsueh PR, Yu CJ, Chien JY.
    Int J Antimicrob Agents; 2024 Jan 15; 63(1):107019. PubMed ID: 37925109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.